Researchers studying the differential expression of microRNA say they may have discovered a way to treat autism by reversing the effects of the disease.
Taken together with recently published research regarding “DNA tagging” by methylation, they say their new study in Genome medicine illustrates two different “epigenetic” mechanisms controlling gene activity in autism that lie beyond genetic mutations. While methylation inhibits gene expression at the level of DNA, microRNA inhibits at the level of RNA.
MicroRNA are snippets of RNA, each of which can inhibit the expression of hundreds to more than a thousand genes. The effects of microRNA are also reversible by treatment with complementary “anti-sense” RNA.
The George Washington University team identified changes in the profile of microRNAs between identical twins and sibling pairs, discordant for diagnosis of autism. They discovered that, despite using cells derived originally from blood, brain-specific and brain-related microRNAs were found to be differentially expressed in the autistic samples, and that these microRNAs could potentially regulate genes that control many processes known to be disrupted in autism.
For example, differentially expressed microRNAs were found to regulate genes highly involved in neurological functions and disorders in addition to genes involved in gastrointestinal diseases, circadian rhythm signaling, and steroid hormone metabolism.
The study further shows that by treating the cells with “anti-sense” RNA antagonists to specific microRNA or by employing mimics of a particular microRNA, one can reverse the pattern of expression of a given target gene regulated by that microRNA.
“It is becoming increasingly clear that many factors, genetic as well as epigenetic, contribute to the manifestation of autism spectrum disorders,” said Valerie Hu, from the University's School of Medicine. “Epigenetic factors are particularly interesting as they provide potential mechanisms for introducing environmental effects into this complex disorder.”
Citation: Sarachana et al., 'Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines', Genome Medicine, April 2010, 2(23); doi:10.1186/gm144
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Part I: Bee Deaths Mystery Solved? Neonicotinoids (Neonics) May Actually Help Bee Health
- Diversity Fatigue: Why Businesses Struggle To Close The Gender Gap
- Coffee Lowers Risk Of Alzheimer's Up To 20 Percent
- Interstellar Is A Dangerous Fantasy Of US Colonialism
- Reasons Serious Scientists Should Not Fear The Winnower and other OA Open Review Journals.
- Part II: Bee Deaths And CCD - Flawed Chensheng Lu Harvard Studies Endanger Bees
- Smoking, Drinking And Eating: It's Not About Your Freedom
- "I was looking at The Winnower again this morning, which led me back here. I tried to comment on..."
- "There is no question they were created to cater to universities and are staffed by people from..."
- "And my second link should be not a copy of the first, but this: http://www.nature.com/news/half..."
- "Recently I saw The Conversation remove/censor legitimate comments arguing against an article written..."
- tags because there's no testing..." href="/robert_inventor/why_we_cant_backup_earth_on_mars_the_moon_or_anywhere_else_in_our_solar_system-148364#comment-182183">"Robert, you might want to reformat my post. I intended to highlight only the headlines for easy..."
- Behavioral interventions to prevent progression to diabetes equally effective in men and women
- Gender differences in adaptation to space flight
- Long-term complication rate low in nose job using patient's own rib cartilage
- Survival differences seen for advanced-stage laryngeal cancer
- Effect of once-daily, low-dose aspirin on heart attack deaths and other outcomes